Kelly Bilof
Women's Health · Glendale, AZNPI 1033428255
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Pfizer at 41.6% of the total. Reporting peaked in 2022 at $1,957 and has fallen 90.8% since, to $181 in 2025. Among women's health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $29.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Myovant Sciences Inc.$537
- AbbVie$471
- Sumitomo Pharma America, Inc.$348
- Boston Scientific$343
- Exeltis, USA Inc.$139
- plus $453 from 15 others
What the payments were for
- Consulting fees$1,08028%
- Speaking & faculty fees$54014%
- Food & beverage$2,30559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $1,634 |
| Myovant Sciences Inc. | 25 | $537 |
| AbbVie | 22 | $471 |
| Sumitomo Pharma America, Inc. | 25 | $348 |
| Boston Scientific | 18 | $343 |
| Exeltis, USA Inc. | 9 | $139 |
| Evofem Biosciences, Inc. | 6 | $91 |
| Mayne Pharma Commercial LLC | 5 | $71 |
| Coopersurgical, Inc. | 3 | $50 |
| Hologic Sales And Service, LLC | 2 | $36 |
| Astellas Pharma US Inc | 2 | $32 |
| Agile Therapeutics, Inc. | 2 | $30 |
| Scynexis, Inc. | 2 | $28 |
| Exact Sciences | 1 | $20 |
| GSK | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Bayer | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Merck | 1 | $11 |
| Organon | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$1,307
- NURTEC ODT$540
How this compares
$3,925 in reported general payments places this provider in the 95th percentile of 176 women's health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,464 |
| ValacyclovirValacyclovir Hcl | 12 | $236 |
| Duloxetine Hcl | 12 | $159 |
| Fluconazole | 13 | $84 |
| Triamcinolone Acetonide | 12 | $66 |
| Lorazepam | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other women's health in Glendale
- Nicola MaurerGlendale$1K
- Carol BafaloukosSun City$13K
- Shannon McGrathTempe$7K
- Michelle SzymanowskiGilbert$6K
- Elizabeth BeaverChandler$4K
- Trina LlewellynScottsdale$4K
- Jennifer SchwartzMesa$4K
- Kristin WatrasPhoenix$3K
- Angela HarveySan Tan Valley$3K
- Audrey SteinkampPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.